fda drug shortages semaglutide injection status resolved 2025 FDA: Ozempic and Wegovy shortage is over FDA ends semaglutide shortage, closing

In the STEP 1-3 clinical trials, semaglutide (a weekly dose of 2.4 mg) resulted in a 49% reduction in C-reactive protein (CRP) levels, while a 1 mg weekly dose of semaglutide reduced CRP by 42%, compared to the placebo after 68 weeks

Its commonly used in medical settings and IV therapy to ease symptoms from illness, dehydration, migraines, or hangovers

2023 Aug;70(8):1397-400

Notably, the TGR5 receptor is activated in this process and also stimulates the production of natural GLP-1

Energy, B12, folate, betaine, B6, zinc, protein and redox status influence these routes

The body can store Vitamin B12, unlike many other vitamins needed to remain healthy and does so in the liver